nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—BCHE—breast cancer	0.3	0.719	CbGaD
Triflupromazine—ABCB1—breast cancer	0.118	0.282	CbGaD
Triflupromazine—HTR2B—Raloxifene—breast cancer	0.11	0.323	CbGbCtD
Triflupromazine—Dimetacrine—Tamoxifen—breast cancer	0.0967	0.571	CrCrCtD
Triflupromazine—Promazine—Tamoxifen—breast cancer	0.0726	0.429	CrCrCtD
Triflupromazine—BCHE—Irinotecan—breast cancer	0.0454	0.134	CbGbCtD
Triflupromazine—ABCB1—Toremifene—breast cancer	0.0411	0.121	CbGbCtD
Triflupromazine—ABCB1—Lapatinib—breast cancer	0.03	0.0882	CbGbCtD
Triflupromazine—ABCB1—Vinorelbine—breast cancer	0.0166	0.049	CbGbCtD
Triflupromazine—ABCB1—Tamoxifen—breast cancer	0.015	0.0442	CbGbCtD
Triflupromazine—ABCB1—Mitoxantrone—breast cancer	0.0146	0.0431	CbGbCtD
Triflupromazine—ABCB1—Gemcitabine—breast cancer	0.0129	0.0381	CbGbCtD
Triflupromazine—ABCB1—Paclitaxel—breast cancer	0.0117	0.0344	CbGbCtD
Triflupromazine—ABCB1—Irinotecan—breast cancer	0.0115	0.0339	CbGbCtD
Triflupromazine—ABCB1—Vinblastine—breast cancer	0.0103	0.0302	CbGbCtD
Triflupromazine—ABCB1—Docetaxel—breast cancer	0.00845	0.0249	CbGbCtD
Triflupromazine—ABCB1—Doxorubicin—breast cancer	0.0063	0.0185	CbGbCtD
Triflupromazine—ABCB1—Methotrexate—breast cancer	0.0061	0.018	CbGbCtD
Triflupromazine—Trifluoperazine—S100A4—breast cancer	0.000749	0.187	CrCbGaD
Triflupromazine—Dimetacrine—ACHE—breast cancer	0.000515	0.128	CrCbGaD
Triflupromazine—Ethopropazine—BCHE—breast cancer	0.00018	0.0449	CrCbGaD
Triflupromazine—Cinacalcet—CYP2D6—breast cancer	0.000155	0.0387	CrCbGaD
Triflupromazine—Clomipramine—GSTP1—breast cancer	0.000151	0.0377	CrCbGaD
Triflupromazine—Cinacalcet—CYP3A4—breast cancer	0.000133	0.0332	CrCbGaD
Triflupromazine—Mequitazine—CYP2D6—breast cancer	0.000101	0.0252	CrCbGaD
Triflupromazine—Alimemazine—CYP3A4—breast cancer	0.000101	0.0251	CrCbGaD
Triflupromazine—Diltiazem—CYP2D6—breast cancer	9.08e-05	0.0226	CrCbGaD
Triflupromazine—Mequitazine—CYP3A4—breast cancer	8.69e-05	0.0216	CrCbGaD
Triflupromazine—Diltiazem—CYP3A4—breast cancer	7.79e-05	0.0194	CrCbGaD
Triflupromazine—Pipotiazine—CYP2D6—breast cancer	7.2e-05	0.0179	CrCbGaD
Triflupromazine—Chlorpromazine—BCHE—breast cancer	7.12e-05	0.0177	CrCbGaD
Triflupromazine—Mesoridazine—CYP2D6—breast cancer	7.11e-05	0.0177	CrCbGaD
Triflupromazine—Prochlorperazine—CYP2D6—breast cancer	6.88e-05	0.0171	CrCbGaD
Triflupromazine—Diltiazem—ABCB1—breast cancer	6.49e-05	0.0162	CrCbGaD
Triflupromazine—Fluphenazine—CYP2D6—breast cancer	6.22e-05	0.0155	CrCbGaD
Triflupromazine—Pipotiazine—CYP3A4—breast cancer	6.18e-05	0.0154	CrCbGaD
Triflupromazine—Prochlorperazine—CYP3A4—breast cancer	5.9e-05	0.0147	CrCbGaD
Triflupromazine—Clomipramine—CYP2D6—breast cancer	5.69e-05	0.0142	CrCbGaD
Triflupromazine—Acepromazine—ALB—breast cancer	5.6e-05	0.014	CrCbGaD
Triflupromazine—Thioproperazine—ALB—breast cancer	5.48e-05	0.0136	CrCbGaD
Triflupromazine—Pipotiazine—ALB—breast cancer	5.39e-05	0.0134	CrCbGaD
Triflupromazine—Thioridazine—CYP2D6—breast cancer	5.36e-05	0.0134	CrCbGaD
Triflupromazine—Methotrimeprazine—CYP2D6—breast cancer	5.12e-05	0.0128	CrCbGaD
Triflupromazine—Promethazine—CYP2D6—breast cancer	5.04e-05	0.0126	CrCbGaD
Triflupromazine—Perphenazine—CYP2D6—breast cancer	4.92e-05	0.0123	CrCbGaD
Triflupromazine—Clomipramine—CYP3A4—breast cancer	4.88e-05	0.0122	CrCbGaD
Triflupromazine—Desipramine—CYP2D6—breast cancer	4.58e-05	0.0114	CrCbGaD
Triflupromazine—Fluphenazine—ABCB1—breast cancer	4.44e-05	0.0111	CrCbGaD
Triflupromazine—Clomipramine—ALB—breast cancer	4.26e-05	0.0106	CrCbGaD
Triflupromazine—Perphenazine—CYP3A4—breast cancer	4.22e-05	0.0105	CrCbGaD
Triflupromazine—Clomipramine—ABCB1—breast cancer	4.07e-05	0.0101	CrCbGaD
Triflupromazine—Chlorprothixene—ABCB1—breast cancer	4.05e-05	0.0101	CrCbGaD
Triflupromazine—Desipramine—CYP3A4—breast cancer	3.93e-05	0.00979	CrCbGaD
Triflupromazine—Chlorpromazine—CYP2D6—breast cancer	3.9e-05	0.00973	CrCbGaD
Triflupromazine—Imipramine—CYP2D6—breast cancer	3.88e-05	0.00967	CrCbGaD
Triflupromazine—Promazine—CYP3A4—breast cancer	3.81e-05	0.00948	CrCbGaD
Triflupromazine—Promethazine—ABCB1—breast cancer	3.6e-05	0.00897	CrCbGaD
Triflupromazine—Trifluoperazine—ABCB1—breast cancer	3.55e-05	0.00885	CrCbGaD
Triflupromazine—Chlorpromazine—CYP3A4—breast cancer	3.35e-05	0.00834	CrCbGaD
Triflupromazine—Imipramine—CYP3A4—breast cancer	3.33e-05	0.0083	CrCbGaD
Triflupromazine—Desipramine—ABCB1—breast cancer	3.27e-05	0.00815	CrCbGaD
Triflupromazine—BCHE—nipple—breast cancer	3.22e-05	0.0588	CbGeAlD
Triflupromazine—Chlorpromazine—ALB—breast cancer	2.92e-05	0.00728	CrCbGaD
Triflupromazine—HTR2B—skin of body—breast cancer	2.81e-05	0.0513	CbGeAlD
Triflupromazine—Chlorpromazine—ABCB1—breast cancer	2.79e-05	0.00694	CrCbGaD
Triflupromazine—Imipramine—ABCB1—breast cancer	2.77e-05	0.00691	CrCbGaD
Triflupromazine—HTR2B—endometrium—breast cancer	2.65e-05	0.0483	CbGeAlD
Triflupromazine—HTR2B—uterus—breast cancer	2.44e-05	0.0445	CbGeAlD
Triflupromazine—HTR2B—adipose tissue—breast cancer	2.39e-05	0.0436	CbGeAlD
Triflupromazine—CHRM1—female reproductive system—breast cancer	2.2e-05	0.0403	CbGeAlD
Triflupromazine—HTR2B—female reproductive system—breast cancer	2.19e-05	0.04	CbGeAlD
Triflupromazine—HTR2B—adrenal gland—breast cancer	2.14e-05	0.0391	CbGeAlD
Triflupromazine—BCHE—skin of body—breast cancer	2.06e-05	0.0376	CbGeAlD
Triflupromazine—CHRM2—endocrine gland—breast cancer	2.05e-05	0.0374	CbGeAlD
Triflupromazine—BCHE—endometrium—breast cancer	1.94e-05	0.0355	CbGeAlD
Triflupromazine—DRD2—pituitary gland—breast cancer	1.94e-05	0.0354	CbGeAlD
Triflupromazine—CHRM1—endocrine gland—breast cancer	1.87e-05	0.0341	CbGeAlD
Triflupromazine—BCHE—uterus—breast cancer	1.79e-05	0.0327	CbGeAlD
Triflupromazine—BCHE—pituitary gland—breast cancer	1.76e-05	0.0321	CbGeAlD
Triflupromazine—BCHE—adipose tissue—breast cancer	1.75e-05	0.032	CbGeAlD
Triflupromazine—BCHE—female reproductive system—breast cancer	1.61e-05	0.0294	CbGeAlD
Triflupromazine—BCHE—adrenal gland—breast cancer	1.57e-05	0.0287	CbGeAlD
Triflupromazine—BCHE—bone marrow—breast cancer	1.52e-05	0.0278	CbGeAlD
Triflupromazine—DRD2—endocrine gland—breast cancer	1.5e-05	0.0274	CbGeAlD
Triflupromazine—BCHE—endocrine gland—breast cancer	1.36e-05	0.0249	CbGeAlD
Triflupromazine—HTR2B—lymph node—breast cancer	1.28e-05	0.0234	CbGeAlD
Triflupromazine—ABCB1—embryo—breast cancer	1.27e-05	0.0231	CbGeAlD
Triflupromazine—ABCB1—epithelium—breast cancer	1.03e-05	0.0189	CbGeAlD
Triflupromazine—BCHE—lymph node—breast cancer	9.42e-06	0.0172	CbGeAlD
Triflupromazine—ABCB1—endometrium—breast cancer	9.26e-06	0.0169	CbGeAlD
Triflupromazine—ABCB1—uterus—breast cancer	8.54e-06	0.0156	CbGeAlD
Triflupromazine—ABCB1—pituitary gland—breast cancer	8.38e-06	0.0153	CbGeAlD
Triflupromazine—ABCB1—adipose tissue—breast cancer	8.35e-06	0.0152	CbGeAlD
Triflupromazine—ABCB1—female reproductive system—breast cancer	7.67e-06	0.014	CbGeAlD
Triflupromazine—ABCB1—adrenal gland—breast cancer	7.49e-06	0.0137	CbGeAlD
Triflupromazine—ABCB1—bone marrow—breast cancer	7.25e-06	0.0132	CbGeAlD
Triflupromazine—ABCB1—female gonad—breast cancer	6.98e-06	0.0127	CbGeAlD
Triflupromazine—ABCB1—endocrine gland—breast cancer	6.49e-06	0.0119	CbGeAlD
Triflupromazine—CHRM1—Signaling Pathways—CAV1—breast cancer	5.03e-06	7.36e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—LEP—breast cancer	5.01e-06	7.33e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—HMOX1—breast cancer	5.01e-06	7.33e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ITPR1—breast cancer	4.99e-06	7.31e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—KDR—breast cancer	4.97e-06	7.28e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CAV1—breast cancer	4.96e-06	7.27e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ESR1—breast cancer	4.95e-06	7.25e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—KDR—breast cancer	4.91e-06	7.18e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—PIK3CA—breast cancer	4.9e-06	7.17e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FN1—breast cancer	4.89e-06	7.16e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MDM2—breast cancer	4.88e-06	7.15e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—RAF1—breast cancer	4.86e-06	7.12e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ESR1—breast cancer	4.84e-06	7.09e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—RELA—breast cancer	4.84e-06	7.09e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CXCL8—breast cancer	4.84e-06	7.08e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NFKBIA—breast cancer	4.83e-06	7.07e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ERBB2—breast cancer	4.81e-06	7.05e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—HRAS—breast cancer	4.81e-06	7.04e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FN1—breast cancer	4.78e-06	7.01e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NOTCH1—breast cancer	4.78e-06	7.01e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ESR1—breast cancer	4.78e-06	7e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MTOR—breast cancer	4.75e-06	6.95e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CB—breast cancer	4.75e-06	6.95e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NFKBIA—breast cancer	4.73e-06	6.92e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CDKN1B—breast cancer	4.72e-06	6.92e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FN1—breast cancer	4.72e-06	6.92e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—TYMS—breast cancer	4.72e-06	6.91e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PTEN—breast cancer	4.7e-06	6.88e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NOTCH1—breast cancer	4.68e-06	6.86e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—APC—breast cancer	4.68e-06	6.85e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CG—breast cancer	4.68e-06	6.85e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—KIT—breast cancer	4.68e-06	6.85e-05	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—AKT1—breast cancer	4.67e-06	6.84e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NFKBIA—breast cancer	4.67e-06	6.83e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NCOR1—breast cancer	4.66e-06	6.83e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GSTM1—breast cancer	4.66e-06	6.83e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PLA2G4A—breast cancer	4.66e-06	6.83e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CASP3—breast cancer	4.63e-06	6.78e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EGF—breast cancer	4.62e-06	6.77e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL2—breast cancer	4.62e-06	6.77e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NOTCH1—breast cancer	4.62e-06	6.77e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL6—breast cancer	4.6e-06	6.74e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CG—breast cancer	4.58e-06	6.7e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APC—breast cancer	4.58e-06	6.7e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—KIT—breast cancer	4.58e-06	6.7e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CXCL8—breast cancer	4.56e-06	6.68e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—HRAS—breast cancer	4.53e-06	6.64e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EGF—breast cancer	4.53e-06	6.63e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—KIT—breast cancer	4.52e-06	6.62e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CG—breast cancer	4.52e-06	6.62e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APC—breast cancer	4.52e-06	6.62e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCND1—breast cancer	4.51e-06	6.6e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—JUN—breast cancer	4.5e-06	6.59e-05	CbGpPWpGaD
Triflupromazine—ABCB1—lymph node—breast cancer	4.49e-06	0.0082	CbGeAlD
Triflupromazine—DRD2—Signaling by GPCR—MAPK3—breast cancer	4.48e-06	6.56e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EGF—breast cancer	4.47e-06	6.54e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GPX1—breast cancer	4.47e-06	6.54e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CTNNB1—breast cancer	4.46e-06	6.54e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CDKN1B—breast cancer	4.46e-06	6.52e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP1A1—breast cancer	4.42e-06	6.47e-05	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—AKT1—breast cancer	4.41e-06	6.45e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—BRAF—breast cancer	4.4e-06	6.44e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ERCC2—breast cancer	4.39e-06	6.42e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—MAPK3—breast cancer	4.38e-06	6.42e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MMP9—breast cancer	4.38e-06	6.41e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CASP3—breast cancer	4.37e-06	6.39e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL2—breast cancer	4.36e-06	6.39e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CDKN1A—breast cancer	4.36e-06	6.39e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PTEN—breast cancer	4.35e-06	6.37e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL6—breast cancer	4.34e-06	6.35e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—MAPK3—breast cancer	4.33e-06	6.34e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—BRAF—breast cancer	4.3e-06	6.3e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IGF1—breast cancer	4.28e-06	6.27e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKT2—breast cancer	4.28e-06	6.27e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—EGFR—breast cancer	4.26e-06	6.24e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MAPK8—breast cancer	4.26e-06	6.23e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCND1—breast cancer	4.25e-06	6.22e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—BRAF—breast cancer	4.25e-06	6.22e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—AKT1—breast cancer	4.24e-06	6.22e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—JUN—breast cancer	4.24e-06	6.21e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CTNNB1—breast cancer	4.21e-06	6.16e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IGF1—breast cancer	4.19e-06	6.14e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKT2—breast cancer	4.19e-06	6.13e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—EGFR—breast cancer	4.17e-06	6.11e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IGF1—breast cancer	4.14e-06	6.06e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKT2—breast cancer	4.14e-06	6.06e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MMP9—breast cancer	4.13e-06	6.04e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—MTHFR—breast cancer	4.12e-06	6.04e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—EGFR—breast cancer	4.12e-06	6.03e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CD—breast cancer	4.11e-06	6.02e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CDKN1A—breast cancer	4.11e-06	6.02e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PTEN—breast cancer	4.1e-06	6.01e-05	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—PIK3CA—breast cancer	4.07e-06	5.97e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SERPINE1—breast cancer	4.07e-06	5.96e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SRC—breast cancer	4.03e-06	5.91e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—KRAS—breast cancer	4.03e-06	5.9e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CD—breast cancer	4.03e-06	5.89e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MAPK8—breast cancer	4.01e-06	5.88e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—AKT1—breast cancer	4e-06	5.86e-05	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	3.99e-06	5.84e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SERPINE1—breast cancer	3.98e-06	5.83e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CD—breast cancer	3.97e-06	5.82e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—KRAS—breast cancer	3.94e-06	5.77e-05	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	3.94e-06	5.76e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SERPINE1—breast cancer	3.93e-06	5.75e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—VEGFA—breast cancer	3.93e-06	5.75e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—STAT3—breast cancer	3.89e-06	5.7e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—KRAS—breast cancer	3.89e-06	5.7e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NOS3—breast cancer	3.88e-06	5.69e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SRC—breast cancer	3.8e-06	5.57e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CAV1—breast cancer	3.8e-06	5.57e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NOS3—breast cancer	3.8e-06	5.57e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NOS3—breast cancer	3.75e-06	5.49e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MAPK3—breast cancer	3.72e-06	5.44e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—VEGFA—breast cancer	3.71e-06	5.43e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PIK3CA—breast cancer	3.7e-06	5.42e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MDM2—breast cancer	3.68e-06	5.4e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RAF1—breast cancer	3.67e-06	5.38e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—STAT3—breast cancer	3.67e-06	5.37e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RELA—breast cancer	3.66e-06	5.35e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ERBB2—breast cancer	3.63e-06	5.32e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	3.62e-06	5.3e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MYC—breast cancer	3.62e-06	5.29e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TGFB1—breast cancer	3.61e-06	5.28e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MDM2—breast cancer	3.61e-06	5.28e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RAF1—breast cancer	3.59e-06	5.26e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MTOR—breast cancer	3.58e-06	5.25e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CB—breast cancer	3.58e-06	5.25e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RELA—breast cancer	3.58e-06	5.24e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	3.57e-06	5.23e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MDM2—breast cancer	3.56e-06	5.21e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ERBB2—breast cancer	3.56e-06	5.21e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RAF1—breast cancer	3.55e-06	5.19e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—EGFR—breast cancer	3.54e-06	5.18e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RELA—breast cancer	3.53e-06	5.17e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ERBB2—breast cancer	3.51e-06	5.14e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MTOR—breast cancer	3.51e-06	5.14e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CB—breast cancer	3.51e-06	5.14e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MAPK3—breast cancer	3.51e-06	5.13e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CG—breast cancer	3.46e-06	5.07e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CB—breast cancer	3.46e-06	5.07e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MTOR—breast cancer	3.46e-06	5.07e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCL8—breast cancer	3.44e-06	5.04e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—HRAS—breast cancer	3.42e-06	5.01e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MYC—breast cancer	3.41e-06	4.99e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TGFB1—breast cancer	3.4e-06	4.98e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCL8—breast cancer	3.37e-06	4.94e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CDKN1B—breast cancer	3.36e-06	4.93e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—HRAS—breast cancer	3.35e-06	4.9e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—KRAS—breast cancer	3.34e-06	4.89e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—EGFR—breast cancer	3.33e-06	4.88e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCL8—breast cancer	3.33e-06	4.87e-05	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—AKT1—breast cancer	3.33e-06	4.87e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3CA—breast cancer	3.32e-06	4.86e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—HRAS—breast cancer	3.31e-06	4.84e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CASP3—breast cancer	3.3e-06	4.83e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CDKN1B—breast cancer	3.29e-06	4.82e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL2—breast cancer	3.29e-06	4.82e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL6—breast cancer	3.28e-06	4.8e-05	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—AKT1—breast cancer	3.26e-06	4.77e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CDKN1B—breast cancer	3.25e-06	4.76e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CASP3—breast cancer	3.23e-06	4.73e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL2—breast cancer	3.22e-06	4.72e-05	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—AKT1—breast cancer	3.21e-06	4.71e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCND1—breast cancer	3.21e-06	4.7e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL6—breast cancer	3.21e-06	4.69e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—JUN—breast cancer	3.2e-06	4.69e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CASP3—breast cancer	3.19e-06	4.66e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL2—breast cancer	3.18e-06	4.66e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CTNNB1—breast cancer	3.18e-06	4.65e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL6—breast cancer	3.16e-06	4.63e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—KRAS—breast cancer	3.15e-06	4.61e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCND1—breast cancer	3.14e-06	4.6e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—JUN—breast cancer	3.13e-06	4.59e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MMP9—breast cancer	3.12e-06	4.56e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CTNNB1—breast cancer	3.11e-06	4.55e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CDKN1A—breast cancer	3.1e-06	4.55e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCND1—breast cancer	3.1e-06	4.54e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PTEN—breast cancer	3.1e-06	4.54e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—JUN—breast cancer	3.09e-06	4.53e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CTNNB1—breast cancer	3.07e-06	4.5e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3CA—breast cancer	3.07e-06	4.49e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MMP9—breast cancer	3.05e-06	4.47e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CD—breast cancer	3.04e-06	4.46e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CDKN1A—breast cancer	3.04e-06	4.45e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PTEN—breast cancer	3.03e-06	4.44e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MAPK8—breast cancer	3.03e-06	4.44e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—AKT1—breast cancer	3.02e-06	4.43e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MMP9—breast cancer	3.01e-06	4.41e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ALB—breast cancer	3.01e-06	4.4e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CDKN1A—breast cancer	3e-06	4.39e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PTEN—breast cancer	2.99e-06	4.38e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TP53—breast cancer	2.97e-06	4.35e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MAPK8—breast cancer	2.97e-06	4.34e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—AKT1—breast cancer	2.96e-06	4.33e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MAPK8—breast cancer	2.93e-06	4.29e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—AKT1—breast cancer	2.92e-06	4.28e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CA—breast cancer	2.89e-06	4.24e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NOS3—breast cancer	2.87e-06	4.21e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SRC—breast cancer	2.87e-06	4.21e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HRAS—breast cancer	2.84e-06	4.16e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SRC—breast cancer	2.81e-06	4.12e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TP53—breast cancer	2.8e-06	4.1e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—VEGFA—breast cancer	2.8e-06	4.1e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SRC—breast cancer	2.78e-06	4.06e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—STAT3—breast cancer	2.77e-06	4.06e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—VEGFA—breast cancer	2.74e-06	4.01e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL6—breast cancer	2.72e-06	3.98e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—STAT3—breast cancer	2.71e-06	3.97e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—AKT1—breast cancer	2.71e-06	3.97e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—VEGFA—breast cancer	2.7e-06	3.96e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HRAS—breast cancer	2.68e-06	3.92e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—STAT3—breast cancer	2.68e-06	3.92e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CB—breast cancer	2.65e-06	3.89e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MAPK3—breast cancer	2.65e-06	3.88e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTGS2—breast cancer	2.63e-06	3.85e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MAPK3—breast cancer	2.59e-06	3.79e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MYC—breast cancer	2.57e-06	3.77e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TGFB1—breast cancer	2.57e-06	3.76e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL6—breast cancer	2.56e-06	3.75e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MAPK3—breast cancer	2.56e-06	3.74e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MYC—breast cancer	2.52e-06	3.69e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EGFR—breast cancer	2.52e-06	3.69e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TGFB1—breast cancer	2.51e-06	3.68e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AKT1—breast cancer	2.51e-06	3.67e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MYC—breast cancer	2.49e-06	3.64e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TGFB1—breast cancer	2.48e-06	3.63e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EGFR—breast cancer	2.46e-06	3.61e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EGFR—breast cancer	2.43e-06	3.56e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—KRAS—breast cancer	2.38e-06	3.48e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AKT1—breast cancer	2.36e-06	3.46e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—KRAS—breast cancer	2.33e-06	3.41e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—KRAS—breast cancer	2.3e-06	3.36e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTEN—breast cancer	2.29e-06	3.36e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CA—breast cancer	2.19e-06	3.2e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CA—breast cancer	2.14e-06	3.13e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TP53—breast cancer	2.11e-06	3.1e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	2.11e-06	3.09e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TP53—breast cancer	2.07e-06	3.03e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TP53—breast cancer	2.04e-06	2.99e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HRAS—breast cancer	2.02e-06	2.96e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HRAS—breast cancer	1.98e-06	2.9e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HRAS—breast cancer	1.95e-06	2.86e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL6—breast cancer	1.94e-06	2.83e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL6—breast cancer	1.89e-06	2.77e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL6—breast cancer	1.87e-06	2.74e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKT1—breast cancer	1.79e-06	2.61e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKT1—breast cancer	1.75e-06	2.56e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKT1—breast cancer	1.72e-06	2.53e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CA—breast cancer	1.62e-06	2.37e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AKT1—breast cancer	1.32e-06	1.94e-05	CbGpPWpGaD
